Home · Solutions

PANCRA by Sycai

The world’s first MDR-approved AI-solution to improve diagnosis of pancreatic lesions

AI solution that improves the diagnosis and follow-up of pancreatic lesions on CT scans. Detects pre-cancerous cysts and malignancies, with and without contrast.

Proven performance in pancreatic leasion detection

Works across scanner vendors and acquisition protocols.

Sensitivity of Detection

96.6 %

Standard of care surpassed

Specificity on Detection

88.3 %

High precision, low false positives

False Negative Rate

3.8 %

In detection

Incidenctal Radiological Findings

3 x

Higher detection vs. clinical practice

How PANCRA™ works

Solution Features

Opportunistic detection of findings

Automates the identification of known or incidental lesions, with no manual trigger, flagging findings on any abdominal CT scan regardless of the reason it was ordered. With and without contrast.

Provides detailed lesion 2D & 3D measurements and precise anatomical location, structured and ready to include in the radiological report.

Sycai Medical holds the only patent enabling automatic single-lesion tracking over time across multiple patient studies, ensuring standardized, consistent follow-up with no manual intervention.

PANCRA™ works as a zero-click AI assistant, delivering findings automatically within the radiologist’s existing workflow. Seamlessly integrated into the PACS: no additional clicks, no setup changes required.

PANCRA™ is CE-Marked and ready to deploy

Clinically certified under EU MDR (Regulation 2017/745) and backed by ISO 13485 quality management. PANCRA™ is a market-ready medical device software, approved for use in adult patients.